| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myasthenic Syndromes, Congenital | 17 | 2018 | 35 | 3.580 |
Why?
|
| Neuromuscular Junction | 20 | 2013 | 80 | 1.400 |
Why?
|
| Muscle Proteins | 8 | 2012 | 132 | 1.200 |
Why?
|
| Myasthenia Gravis | 13 | 2013 | 83 | 1.130 |
Why?
|
| Receptors, Cholinergic | 15 | 2011 | 76 | 0.910 |
Why?
|
| Laminin | 4 | 2012 | 85 | 0.600 |
Why?
|
| Synapses | 4 | 2012 | 265 | 0.520 |
Why?
|
| Catatonia | 1 | 2014 | 8 | 0.510 |
Why?
|
| Mutation | 14 | 2012 | 3968 | 0.500 |
Why?
|
| Nerve Tissue Proteins | 13 | 2018 | 503 | 0.500 |
Why?
|
| Electroconvulsive Therapy | 1 | 2014 | 24 | 0.490 |
Why?
|
| Muscle, Skeletal | 16 | 2011 | 449 | 0.490 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2013 | 4 | 0.460 |
Why?
|
| Receptors, Nicotinic | 3 | 2010 | 129 | 0.440 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2011 | 153 | 0.440 |
Why?
|
| Basement Membrane | 1 | 2012 | 54 | 0.430 |
Why?
|
| Exome | 1 | 2013 | 127 | 0.430 |
Why?
|
| Plectin | 1 | 2010 | 1 | 0.400 |
Why?
|
| Epidermolysis Bullosa Simplex | 1 | 2010 | 2 | 0.400 |
Why?
|
| Motor Endplate | 12 | 2012 | 31 | 0.370 |
Why?
|
| Point Mutation | 3 | 2007 | 246 | 0.360 |
Why?
|
| Pedigree | 6 | 2013 | 966 | 0.330 |
Why?
|
| Electromyography | 12 | 2013 | 183 | 0.330 |
Why?
|
| Agrin | 3 | 2012 | 6 | 0.310 |
Why?
|
| Microscopy, Electron | 14 | 2018 | 503 | 0.310 |
Why?
|
| Muscles | 10 | 2004 | 194 | 0.310 |
Why?
|
| Presynaptic Terminals | 2 | 2011 | 40 | 0.300 |
Why?
|
| DNA Mutational Analysis | 7 | 2013 | 526 | 0.290 |
Why?
|
| Collagen | 4 | 2012 | 269 | 0.290 |
Why?
|
| Tuberous Sclerosis | 5 | 2003 | 28 | 0.290 |
Why?
|
| Mutation, Missense | 4 | 2011 | 276 | 0.280 |
Why?
|
| Mice | 36 | 2012 | 11352 | 0.270 |
Why?
|
| Disease Models, Animal | 17 | 2011 | 2232 | 0.270 |
Why?
|
| Synaptic Transmission | 6 | 2018 | 222 | 0.250 |
Why?
|
| Animals | 61 | 2012 | 26582 | 0.250 |
Why?
|
| Theilovirus | 4 | 2011 | 39 | 0.250 |
Why?
|
| Female | 56 | 2018 | 44532 | 0.250 |
Why?
|
| Heterozygote | 6 | 2018 | 365 | 0.250 |
Why?
|
| Fatal Outcome | 6 | 2014 | 293 | 0.250 |
Why?
|
| Nerve Degeneration | 5 | 2008 | 83 | 0.240 |
Why?
|
| Humans | 75 | 2018 | 86643 | 0.240 |
Why?
|
| Brain Neoplasms | 4 | 2013 | 763 | 0.240 |
Why?
|
| Demyelinating Diseases | 5 | 2011 | 68 | 0.240 |
Why?
|
| Brain | 15 | 2010 | 2216 | 0.240 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2003 | 23 | 0.230 |
Why?
|
| Prions | 5 | 2007 | 54 | 0.220 |
Why?
|
| Spinal Nerve Roots | 1 | 2002 | 17 | 0.220 |
Why?
|
| Neurofibromatoses | 1 | 2002 | 9 | 0.220 |
Why?
|
| Male | 46 | 2014 | 40965 | 0.220 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2002 | 10 | 0.220 |
Why?
|
| Acetylcholine | 1 | 2003 | 176 | 0.220 |
Why?
|
| Mice, Transgenic | 16 | 2011 | 1540 | 0.220 |
Why?
|
| RNA, Viral | 6 | 2011 | 327 | 0.200 |
Why?
|
| Neurotransmitter Agents | 1 | 2001 | 106 | 0.190 |
Why?
|
| Neuroglia | 6 | 2004 | 104 | 0.190 |
Why?
|
| Codon, Nonsense | 2 | 2011 | 41 | 0.190 |
Why?
|
| Neurons | 6 | 2011 | 1546 | 0.180 |
Why?
|
| Cell Line | 7 | 2011 | 2468 | 0.180 |
Why?
|
| Histoplasma | 1 | 1998 | 13 | 0.170 |
Why?
|
| Histoplasmosis | 1 | 1998 | 25 | 0.170 |
Why?
|
| Oligodendroglia | 6 | 2011 | 123 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 78 | 0.160 |
Why?
|
| Neurologic Examination | 3 | 2014 | 118 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 63 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 5 | 2001 | 223 | 0.160 |
Why?
|
| Acetylcholinesterase | 3 | 2012 | 47 | 0.150 |
Why?
|
| Aspartic Acid | 3 | 2013 | 64 | 0.150 |
Why?
|
| Autoantibodies | 4 | 2011 | 267 | 0.150 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2010 | 87 | 0.150 |
Why?
|
| Ganglioglioma | 1 | 1996 | 4 | 0.150 |
Why?
|
| Organelles | 1 | 1997 | 52 | 0.150 |
Why?
|
| Ataxia | 3 | 2003 | 37 | 0.140 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 1998 | 57 | 0.140 |
Why?
|
| Immunization, Passive | 4 | 1993 | 71 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 302 | 0.140 |
Why?
|
| Neural Conduction | 4 | 2007 | 69 | 0.140 |
Why?
|
| Protein Binding | 5 | 2012 | 1456 | 0.140 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 1995 | 7 | 0.140 |
Why?
|
| Cell Membrane | 3 | 2006 | 666 | 0.140 |
Why?
|
| Prion Diseases | 2 | 2007 | 32 | 0.130 |
Why?
|
| Biopsy | 12 | 2012 | 1163 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 232 | 0.130 |
Why?
|
| 4-Aminopyridine | 2 | 2013 | 32 | 0.130 |
Why?
|
| Dystrophin | 3 | 2007 | 21 | 0.130 |
Why?
|
| Capsid | 2 | 1996 | 34 | 0.130 |
Why?
|
| Child | 10 | 2018 | 6927 | 0.130 |
Why?
|
| Middle Aged | 25 | 2013 | 25028 | 0.130 |
Why?
|
| Cytosol | 2 | 2006 | 189 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 2271 | 0.120 |
Why?
|
| Rats | 15 | 2011 | 3990 | 0.120 |
Why?
|
| Protein Kinases | 2 | 1998 | 209 | 0.120 |
Why?
|
| Central Nervous System | 3 | 2008 | 151 | 0.120 |
Why?
|
| Infant | 6 | 2012 | 3046 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 879 | 0.120 |
Why?
|
| Base Sequence | 4 | 2013 | 2330 | 0.120 |
Why?
|
| Immunosuppressive Agents | 4 | 2009 | 977 | 0.120 |
Why?
|
| Neostigmine | 1 | 2013 | 6 | 0.120 |
Why?
|
| Myelin Sheath | 6 | 2008 | 84 | 0.110 |
Why?
|
| Rats, Inbred Lew | 9 | 2011 | 186 | 0.110 |
Why?
|
| Poliomyelitis | 5 | 2011 | 28 | 0.110 |
Why?
|
| Strabismus | 1 | 2012 | 10 | 0.110 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2012 | 9 | 0.110 |
Why?
|
| Dynamin II | 1 | 2012 | 15 | 0.110 |
Why?
|
| Toxoplasma | 2 | 2010 | 108 | 0.110 |
Why?
|
| Oculomotor Muscles | 1 | 2012 | 28 | 0.110 |
Why?
|
| Bungarotoxins | 4 | 2011 | 25 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 3030 | 0.110 |
Why?
|
| Irritable Mood | 1 | 2012 | 10 | 0.110 |
Why?
|
| Adolescent | 10 | 2008 | 8981 | 0.110 |
Why?
|
| Meningitis, Bacterial | 1 | 2012 | 13 | 0.110 |
Why?
|
| Carrier Proteins | 3 | 2005 | 673 | 0.110 |
Why?
|
| Transfection | 4 | 2007 | 896 | 0.110 |
Why?
|
| Maus Elberfeld virus | 2 | 1989 | 34 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2011 | 615 | 0.110 |
Why?
|
| Thymoma | 2 | 1998 | 30 | 0.110 |
Why?
|
| Glioblastoma | 2 | 2010 | 255 | 0.100 |
Why?
|
| Neuromuscular Diseases | 2 | 1996 | 30 | 0.100 |
Why?
|
| Thymus Neoplasms | 2 | 1998 | 41 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 1992 | 119 | 0.100 |
Why?
|
| Apoptosis | 5 | 2007 | 1683 | 0.100 |
Why?
|
| Encephalitis | 3 | 2008 | 104 | 0.100 |
Why?
|
| Hypotension, Orthostatic | 1 | 2011 | 5 | 0.100 |
Why?
|
| Muscular Dystrophies | 3 | 2007 | 54 | 0.100 |
Why?
|
| Sympathectomy | 1 | 1992 | 42 | 0.100 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2013 | 164 | 0.100 |
Why?
|
| Fever | 1 | 2012 | 125 | 0.100 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 73 | 0.100 |
Why?
|
| Membrane Glycoproteins | 3 | 2001 | 428 | 0.100 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2010 | 6 | 0.100 |
Why?
|
| Inflammation | 3 | 1992 | 920 | 0.100 |
Why?
|
| Autoimmune Diseases | 2 | 1998 | 241 | 0.100 |
Why?
|
| Consanguinity | 1 | 2010 | 73 | 0.100 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 1 | 2010 | 5 | 0.100 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2011 | 45 | 0.100 |
Why?
|
| Ribosomal Proteins | 1 | 2010 | 43 | 0.100 |
Why?
|
| Aged | 13 | 2013 | 18415 | 0.100 |
Why?
|
| Virulence Factors | 1 | 2011 | 108 | 0.100 |
Why?
|
| Cell Death | 1 | 2011 | 256 | 0.090 |
Why?
|
| Survival | 1 | 2010 | 21 | 0.090 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 111 | 0.090 |
Why?
|
| Protozoan Proteins | 1 | 2010 | 73 | 0.090 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2010 | 18 | 0.090 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 52 | 0.090 |
Why?
|
| Homeostasis | 2 | 2018 | 409 | 0.090 |
Why?
|
| S100 Proteins | 4 | 1982 | 50 | 0.090 |
Why?
|
| Viral Proteins | 2 | 2011 | 300 | 0.090 |
Why?
|
| Schwann Cells | 5 | 2011 | 34 | 0.090 |
Why?
|
| Nausea | 1 | 2011 | 175 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 305 | 0.090 |
Why?
|
| Enterovirus | 1 | 1989 | 34 | 0.090 |
Why?
|
| Autoantigens | 3 | 1997 | 127 | 0.090 |
Why?
|
| Weight Loss | 1 | 2011 | 229 | 0.090 |
Why?
|
| Child, Preschool | 4 | 2007 | 3612 | 0.090 |
Why?
|
| Calcium | 4 | 2006 | 1156 | 0.090 |
Why?
|
| PrPSc Proteins | 2 | 2006 | 22 | 0.090 |
Why?
|
| Propylene Glycols | 1 | 2009 | 30 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 456 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 255 | 0.090 |
Why?
|
| Thiophenes | 1 | 2009 | 48 | 0.090 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2009 | 8 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 937 | 0.090 |
Why?
|
| Hodgkin Disease | 2 | 2001 | 177 | 0.090 |
Why?
|
| Polyneuropathies | 1 | 2009 | 27 | 0.090 |
Why?
|
| Spinal Cord | 7 | 2008 | 249 | 0.090 |
Why?
|
| Oxadiazoles | 1 | 2009 | 46 | 0.090 |
Why?
|
| Sphingosine | 1 | 2009 | 71 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 330 | 0.090 |
Why?
|
| Canavan Disease | 1 | 2008 | 1 | 0.090 |
Why?
|
| Phenotype | 6 | 2012 | 2378 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 383 | 0.090 |
Why?
|
| Craniopharyngioma | 1 | 2009 | 11 | 0.090 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2008 | 6 | 0.080 |
Why?
|
| Sella Turcica | 1 | 2009 | 17 | 0.080 |
Why?
|
| Amidohydrolases | 1 | 2008 | 18 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 1990 | 456 | 0.080 |
Why?
|
| Enterovirus Infections | 2 | 1989 | 41 | 0.080 |
Why?
|
| Adult | 25 | 2012 | 25648 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2010 | 502 | 0.080 |
Why?
|
| Immunohistochemistry | 6 | 2012 | 1753 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2009 | 62 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2009 | 100 | 0.080 |
Why?
|
| Hypothalamus, Middle | 1 | 1988 | 4 | 0.080 |
Why?
|
| Somatosensory Disorders | 1 | 2007 | 3 | 0.080 |
Why?
|
| Autoimmunity | 1 | 2009 | 160 | 0.080 |
Why?
|
| Dyneins | 1 | 2007 | 14 | 0.080 |
Why?
|
| Hyperphagia | 1 | 1988 | 35 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 47 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2010 | 1578 | 0.080 |
Why?
|
| Hypothalamus | 1 | 1988 | 79 | 0.080 |
Why?
|
| Young Adult | 2 | 2010 | 5976 | 0.080 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2010 | 223 | 0.080 |
Why?
|
| Genes, Recessive | 1 | 2007 | 87 | 0.080 |
Why?
|
| Motor Neurons | 3 | 1995 | 162 | 0.070 |
Why?
|
| Calpain | 1 | 2007 | 111 | 0.070 |
Why?
|
| Homozygote | 2 | 2005 | 200 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 5 | 2002 | 396 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2007 | 557 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2013 | 3362 | 0.070 |
Why?
|
| Non-Fibrillar Collagens | 2 | 1997 | 3 | 0.070 |
Why?
|
| Hexosaminidases | 1 | 1986 | 7 | 0.070 |
Why?
|
| Gene Expression | 3 | 2006 | 1284 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 189 | 0.070 |
Why?
|
| Gene Expression Regulation | 4 | 2010 | 1920 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2007 | 329 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2008 | 3092 | 0.070 |
Why?
|
| Body Weight | 1 | 1988 | 459 | 0.070 |
Why?
|
| Glycoproteins | 2 | 2007 | 234 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 339 | 0.070 |
Why?
|
| Receptors, GABA-A | 1 | 2005 | 32 | 0.070 |
Why?
|
| Muscle Hypertonia | 1 | 2005 | 17 | 0.070 |
Why?
|
| Spinal Diseases | 1 | 2006 | 44 | 0.070 |
Why?
|
| Feeding and Eating Disorders | 1 | 1988 | 173 | 0.070 |
Why?
|
| Exons | 1 | 2007 | 450 | 0.070 |
Why?
|
| Ganglioneuroma | 1 | 2005 | 9 | 0.070 |
Why?
|
| Cauda Equina | 1 | 2005 | 13 | 0.070 |
Why?
|
| Paraganglioma | 1 | 2005 | 16 | 0.070 |
Why?
|
| Epitopes | 3 | 1998 | 255 | 0.070 |
Why?
|
| Lipid Bilayers | 1 | 2006 | 134 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2006 | 281 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2009 | 1565 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1464 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2012 | 535 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2004 | 32 | 0.060 |
Why?
|
| Electric Stimulation | 3 | 2011 | 347 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 2062 | 0.060 |
Why?
|
| Soft Tissue Neoplasms | 2 | 1982 | 127 | 0.060 |
Why?
|
| Synaptic Membranes | 1 | 2003 | 14 | 0.060 |
Why?
|
| Action Potentials | 5 | 2011 | 573 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6509 | 0.060 |
Why?
|
| Terbutaline | 2 | 1994 | 16 | 0.060 |
Why?
|
| Cerebellar Neoplasms | 2 | 1984 | 36 | 0.060 |
Why?
|
| Caspases | 1 | 2004 | 155 | 0.060 |
Why?
|
| Hydrocephalus | 1 | 1984 | 101 | 0.060 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2003 | 4 | 0.060 |
Why?
|
| Time Factors | 7 | 1996 | 5210 | 0.060 |
Why?
|
| Neoplasms, Muscle Tissue | 2 | 1982 | 11 | 0.060 |
Why?
|
| Paraparesis | 1 | 2002 | 4 | 0.060 |
Why?
|
| Hypertrophy | 1 | 2002 | 62 | 0.060 |
Why?
|
| Radiculopathy | 1 | 2002 | 15 | 0.060 |
Why?
|
| Hemangioma | 1 | 1983 | 60 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2003 | 134 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2004 | 340 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2002 | 61 | 0.050 |
Why?
|
| Ultrasonography | 1 | 1984 | 695 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 1984 | 262 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 1983 | 121 | 0.050 |
Why?
|
| Hypertension | 1 | 2010 | 1141 | 0.050 |
Why?
|
| Family | 1 | 2003 | 311 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 6 | 1996 | 1376 | 0.050 |
Why?
|
| Cricetinae | 5 | 2008 | 560 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2001 | 69 | 0.050 |
Why?
|
| Intracranial Aneurysm | 2 | 2001 | 158 | 0.050 |
Why?
|
| Cholinesterases | 3 | 2011 | 17 | 0.050 |
Why?
|
| Proteins | 1 | 2007 | 777 | 0.050 |
Why?
|
| Spinal Neoplasms | 1 | 2001 | 50 | 0.050 |
Why?
|
| Intracranial Pressure | 1 | 2001 | 77 | 0.050 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2001 | 21 | 0.050 |
Why?
|
| Aneurysm, False | 1 | 2001 | 54 | 0.050 |
Why?
|
| Rats, Inbred Strains | 3 | 1992 | 312 | 0.050 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2000 | 1 | 0.050 |
Why?
|
| Behavior, Animal | 3 | 2008 | 373 | 0.050 |
Why?
|
| Dystroglycans | 3 | 2011 | 15 | 0.050 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 1981 | 13 | 0.050 |
Why?
|
| Foam Cells | 1 | 2000 | 17 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1981 | 38 | 0.050 |
Why?
|
| Seizures | 1 | 2003 | 297 | 0.050 |
Why?
|
| Oocytes | 2 | 2002 | 221 | 0.050 |
Why?
|
| Antibodies, Viral | 4 | 1996 | 293 | 0.050 |
Why?
|
| Cerebral Ventricles | 2 | 1995 | 76 | 0.050 |
Why?
|
| Radiography | 1 | 2002 | 813 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2010 | 782 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2003 | 403 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1981 | 111 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2001 | 268 | 0.050 |
Why?
|
| Xenopus laevis | 2 | 1997 | 137 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2013 | 318 | 0.050 |
Why?
|
| Astrocytoma | 2 | 1995 | 82 | 0.040 |
Why?
|
| Spinal Cord Diseases | 1 | 1979 | 29 | 0.040 |
Why?
|
| Cerebral Cortex | 4 | 2003 | 584 | 0.040 |
Why?
|
| Mice, SCID | 3 | 1996 | 252 | 0.040 |
Why?
|
| Respirovirus Infections | 1 | 1979 | 12 | 0.040 |
Why?
|
| Paramyxoviridae | 1 | 1979 | 10 | 0.040 |
Why?
|
| Bromhexine | 2 | 1978 | 2 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 134 | 0.040 |
Why?
|
| Genotype | 1 | 2003 | 1851 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2001 | 325 | 0.040 |
Why?
|
| Nuclear Warfare | 1 | 1978 | 4 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2018 | 32 | 0.040 |
Why?
|
| Brain Stem | 2 | 1997 | 165 | 0.040 |
Why?
|
| RNA, Messenger | 5 | 2005 | 1981 | 0.040 |
Why?
|
| Botulism | 1 | 1997 | 6 | 0.040 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 1997 | 3 | 0.040 |
Why?
|
| Kidney | 3 | 2008 | 1241 | 0.040 |
Why?
|
| Heat Stroke | 1 | 1997 | 9 | 0.040 |
Why?
|
| Neurotoxins | 1 | 1997 | 49 | 0.040 |
Why?
|
| Kinetics | 2 | 1997 | 1513 | 0.040 |
Why?
|
| Rabbits | 4 | 1990 | 636 | 0.040 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 1996 | 5 | 0.040 |
Why?
|
| Meninges | 1 | 1996 | 13 | 0.040 |
Why?
|
| Cell Survival | 3 | 2009 | 969 | 0.040 |
Why?
|
| Tacrolimus | 1 | 1998 | 373 | 0.040 |
Why?
|
| Myositis | 1 | 1996 | 17 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2008 | 510 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2001 | 2601 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 1996 | 94 | 0.040 |
Why?
|
| Myocarditis | 1 | 1996 | 50 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 1997 | 151 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2010 | 316 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1996 | 123 | 0.040 |
Why?
|
| Inclusion Bodies | 2 | 2005 | 34 | 0.040 |
Why?
|
| Mice, Inbred Strains | 4 | 1996 | 307 | 0.030 |
Why?
|
| Burns, Electric | 1 | 1995 | 5 | 0.030 |
Why?
|
| Connectin | 2 | 1998 | 5 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 1995 | 17 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2009 | 927 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 1996 | 229 | 0.030 |
Why?
|
| Postpoliomyelitis Syndrome | 1 | 1995 | 6 | 0.030 |
Why?
|
| Desmosomes | 1 | 1995 | 10 | 0.030 |
Why?
|
| Skin Abnormalities | 1 | 1995 | 11 | 0.030 |
Why?
|
| Hindlimb | 2 | 2011 | 89 | 0.030 |
Why?
|
| Pemphigoid, Bullous | 1 | 1995 | 12 | 0.030 |
Why?
|
| Muscle Hypotonia | 1 | 1995 | 45 | 0.030 |
Why?
|
| Defective Viruses | 1 | 1995 | 12 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 1995 | 36 | 0.030 |
Why?
|
| Tibial Nerve | 1 | 1995 | 14 | 0.030 |
Why?
|
| Axonal Transport | 1 | 1995 | 31 | 0.030 |
Why?
|
| Leupeptins | 2 | 2006 | 21 | 0.030 |
Why?
|
| Hypoglossal Nerve | 1 | 1995 | 26 | 0.030 |
Why?
|
| Neutrons | 1 | 1995 | 58 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2006 | 53 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 1996 | 552 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 1995 | 35 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1995 | 50 | 0.030 |
Why?
|
| Capsid Proteins | 2 | 1996 | 32 | 0.030 |
Why?
|
| Neutralization Tests | 2 | 1996 | 77 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1997 | 231 | 0.030 |
Why?
|
| Neuritis, Autoimmune, Experimental | 1 | 1994 | 7 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 1981 | 1458 | 0.030 |
Why?
|
| Ion Channels | 1 | 1996 | 246 | 0.030 |
Why?
|
| Peripheral Nerves | 2 | 1992 | 36 | 0.030 |
Why?
|
| Electrophysiology | 2 | 2009 | 401 | 0.030 |
Why?
|
| Age Factors | 2 | 2008 | 1851 | 0.030 |
Why?
|
| Spleen | 2 | 2009 | 430 | 0.030 |
Why?
|
| Adenoviridae | 1 | 1995 | 345 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1995 | 439 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2004 | 121 | 0.030 |
Why?
|
| Disease Progression | 2 | 2008 | 1531 | 0.030 |
Why?
|
| Cell Count | 2 | 2007 | 195 | 0.030 |
Why?
|
| Aging | 1 | 1978 | 691 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2004 | 122 | 0.030 |
Why?
|
| Electroshock | 1 | 1992 | 17 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2007 | 1924 | 0.030 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2012 | 25 | 0.030 |
Why?
|
| Histocytochemistry | 3 | 1998 | 130 | 0.030 |
Why?
|
| Blood | 1 | 2012 | 69 | 0.030 |
Why?
|
| Culture Media | 1 | 2012 | 147 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2011 | 42 | 0.030 |
Why?
|
| Median Nerve | 1 | 2011 | 11 | 0.030 |
Why?
|
| Astrocytes | 2 | 2004 | 139 | 0.030 |
Why?
|
| Diaphragm | 1 | 2011 | 50 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2012 | 71 | 0.030 |
Why?
|
| Forearm | 1 | 1991 | 32 | 0.030 |
Why?
|
| Cerebral Angiography | 2 | 2001 | 196 | 0.030 |
Why?
|
| Rodent Diseases | 1 | 2011 | 34 | 0.030 |
Why?
|
| Tetracyclines | 1 | 2010 | 4 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2010 | 21 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1992 | 435 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 332 | 0.020 |
Why?
|
| Viruses, Unclassified | 1 | 1970 | 1 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 158 | 0.020 |
Why?
|
| Anemia, Hemolytic | 1 | 1970 | 19 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2010 | 25 | 0.020 |
Why?
|
| Ganglia, Spinal | 2 | 2007 | 72 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2010 | 48 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 236 | 0.020 |
Why?
|
| Blood-Nerve Barrier | 1 | 2009 | 2 | 0.020 |
Why?
|
| Antigens, Viral | 3 | 1996 | 143 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 1982 | 182 | 0.020 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2009 | 29 | 0.020 |
Why?
|
| Injections, Intravenous | 3 | 1981 | 244 | 0.020 |
Why?
|
| Embryo, Mammalian | 2 | 2007 | 207 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 179 | 0.020 |
Why?
|
| Gadolinium | 1 | 2010 | 103 | 0.020 |
Why?
|
| RNA, Catalytic | 1 | 2010 | 129 | 0.020 |
Why?
|
| Nervous System | 2 | 1997 | 86 | 0.020 |
Why?
|
| N-Acylsphingosine Galactosyltransferase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 187 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 1801 | 0.020 |
Why?
|
| Lateral Ventricles | 1 | 2008 | 12 | 0.020 |
Why?
|
| Leukemia Virus, Murine | 1 | 1968 | 18 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2009 | 64 | 0.020 |
Why?
|
| Biomarkers | 2 | 2008 | 1718 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 498 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 188 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2010 | 3241 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2008 | 33 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 853 | 0.020 |
Why?
|
| Glutamine | 1 | 2008 | 76 | 0.020 |
Why?
|
| Atrophy | 1 | 2008 | 117 | 0.020 |
Why?
|
| Evoked Potentials, Motor | 1 | 2008 | 16 | 0.020 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2007 | 4 | 0.020 |
Why?
|
| H-Reflex | 1 | 2007 | 8 | 0.020 |
Why?
|
| Muscle Spindles | 1 | 2007 | 5 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1988 | 35 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2007 | 24 | 0.020 |
Why?
|
| Microglia | 1 | 2008 | 102 | 0.020 |
Why?
|
| Axons | 1 | 2008 | 174 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 148 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1988 | 69 | 0.020 |
Why?
|
| Tumor Virus Infections | 1 | 1988 | 81 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 196 | 0.020 |
Why?
|
| Pentosyltransferases | 1 | 2007 | 35 | 0.020 |
Why?
|
| Necrosis | 2 | 1995 | 204 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1286 | 0.020 |
Why?
|
| Asparagine | 1 | 2007 | 29 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2006 | 19 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2002 | 881 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 115 | 0.020 |
Why?
|
| Myocardium | 2 | 2001 | 529 | 0.020 |
Why?
|
| Administration, Oral | 3 | 1998 | 684 | 0.020 |
Why?
|
| Dystonin | 2 | 1997 | 3 | 0.020 |
Why?
|
| Fetus | 1 | 1988 | 226 | 0.020 |
Why?
|
| Blood Cell Count | 2 | 1981 | 79 | 0.020 |
Why?
|
| Submucous Plexus | 1 | 1986 | 2 | 0.020 |
Why?
|
| Hexosaminidase A | 1 | 1986 | 2 | 0.020 |
Why?
|
| Hexosaminidase B | 1 | 1986 | 3 | 0.020 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 1986 | 4 | 0.020 |
Why?
|
| Syndrome | 3 | 1998 | 446 | 0.020 |
Why?
|
| Muscular Atrophy | 1 | 1987 | 41 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1019 | 0.020 |
Why?
|
| Chondrocalcinosis | 1 | 2006 | 8 | 0.020 |
Why?
|
| Anterior Horn Cells | 1 | 2005 | 3 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2006 | 28 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2005 | 27 | 0.020 |
Why?
|
| Lead Poisoning | 1 | 1986 | 10 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 3 | 1982 | 303 | 0.020 |
Why?
|
| Pons | 1 | 2005 | 24 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1988 | 269 | 0.020 |
Why?
|
| Diazepam | 1 | 2005 | 28 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2006 | 60 | 0.020 |
Why?
|
| Neurons, Afferent | 2 | 1997 | 79 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 36 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2008 | 439 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 93 | 0.020 |
Why?
|
| Gorilla gorilla | 1 | 1986 | 41 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2005 | 49 | 0.020 |
Why?
|
| Haplotypes | 1 | 2008 | 642 | 0.020 |
Why?
|
| Papio | 1 | 1986 | 82 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 425 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 204 | 0.020 |
Why?
|
| Crystallization | 1 | 2006 | 206 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 776 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1074 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1986 | 271 | 0.020 |
Why?
|
| Neuroblastoma | 2 | 2006 | 374 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 1986 | 80 | 0.020 |
Why?
|
| Keratins | 1 | 2005 | 63 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 926 | 0.020 |
Why?
|
| Immune Sera | 3 | 1980 | 52 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2006 | 133 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 1986 | 186 | 0.020 |
Why?
|
| Leukocytes | 1 | 1986 | 202 | 0.020 |
Why?
|
| Cuprizone | 1 | 2004 | 3 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2008 | 971 | 0.020 |
Why?
|
| Gliosis | 1 | 2004 | 35 | 0.020 |
Why?
|
| Kaolin | 1 | 1984 | 9 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 2004 | 49 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1384 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 559 | 0.020 |
Why?
|
| Silicones | 1 | 1984 | 16 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 1997 | 290 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2004 | 64 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2009 | 669 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 492 | 0.020 |
Why?
|
| Mesocricetus | 2 | 1988 | 107 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 2004 | 56 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2004 | 69 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 1984 | 9 | 0.020 |
Why?
|
| Aminophenols | 1 | 2004 | 4 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2004 | 16 | 0.020 |
Why?
|
| Graft Survival | 1 | 1988 | 884 | 0.020 |
Why?
|
| Sheep | 2 | 1981 | 239 | 0.010 |
Why?
|
| DNA, Viral | 3 | 1995 | 265 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2003 | 145 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 1987 | 409 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 162 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 685 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 2 | 1993 | 41 | 0.010 |
Why?
|
| Age of Onset | 1 | 2004 | 310 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1986 | 729 | 0.010 |
Why?
|
| Hypergammaglobulinemia | 1 | 1983 | 8 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2003 | 80 | 0.010 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1983 | 25 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 203 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 1984 | 155 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 1565 | 0.010 |
Why?
|
| Aminocaproates | 1 | 1982 | 4 | 0.010 |
Why?
|
| Aminocaproic Acid | 1 | 1982 | 3 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 64 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1983 | 61 | 0.010 |
Why?
|
| Picornaviridae Infections | 1 | 1982 | 7 | 0.010 |
Why?
|
| Meningioma | 1 | 1983 | 60 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1983 | 154 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 692 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2003 | 182 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 87 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2002 | 100 | 0.010 |
Why?
|
| Glycosylation | 1 | 2002 | 129 | 0.010 |
Why?
|
| Xenopus | 1 | 2002 | 125 | 0.010 |
Why?
|
| Permeability | 1 | 2002 | 137 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2002 | 72 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 100 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1984 | 790 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 351 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1983 | 85 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1982 | 63 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1982 | 116 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1981 | 9 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1984 | 328 | 0.010 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 1981 | 16 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 180 | 0.010 |
Why?
|
| Measles | 1 | 1981 | 15 | 0.010 |
Why?
|
| Melanocytes | 1 | 1982 | 56 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1984 | 1047 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 2001 | 27 | 0.010 |
Why?
|
| Cartilage | 1 | 1982 | 113 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2009 | 7993 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2001 | 4 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 279 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2002 | 283 | 0.010 |
Why?
|
| Sarcoglycans | 1 | 2001 | 13 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 2001 | 52 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 2001 | 49 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1981 | 39 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1981 | 39 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1981 | 91 | 0.010 |
Why?
|
| Protein Transport | 1 | 2002 | 411 | 0.010 |
Why?
|
| Acute Disease | 2 | 1993 | 826 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1981 | 42 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2001 | 87 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 2426 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1041 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 376 | 0.010 |
Why?
|
| Liver | 1 | 1986 | 1230 | 0.010 |
Why?
|
| Protein Folding | 1 | 2002 | 282 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1981 | 91 | 0.010 |
Why?
|
| Macrophages | 2 | 1996 | 554 | 0.010 |
Why?
|
| Eye | 1 | 1981 | 111 | 0.010 |
Why?
|
| Vasculitis | 1 | 1979 | 39 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1981 | 420 | 0.010 |
Why?
|
| Meningitis, Viral | 1 | 1979 | 10 | 0.010 |
Why?
|
| Respiration | 1 | 1981 | 262 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1998 | 18 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1998 | 171 | 0.010 |
Why?
|
| Arteries | 1 | 1979 | 176 | 0.010 |
Why?
|
| Phrenic Nerve | 1 | 1998 | 42 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1981 | 459 | 0.010 |
Why?
|
| Ambroxol | 1 | 1978 | 1 | 0.010 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1978 | 14 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 29 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1997 | 81 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 1997 | 42 | 0.010 |
Why?
|
| Japan | 1 | 1978 | 307 | 0.010 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 1978 | 49 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 229 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1998 | 195 | 0.010 |
Why?
|
| Friend murine leukemia virus | 2 | 1973 | 5 | 0.010 |
Why?
|
| Rhabdomyoma | 1 | 1996 | 2 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 916 | 0.010 |
Why?
|
| Angiomyolipoma | 1 | 1996 | 15 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1997 | 369 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1996 | 79 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1997 | 190 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1998 | 272 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 86 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1998 | 425 | 0.010 |
Why?
|
| Curare | 1 | 1996 | 3 | 0.010 |
Why?
|
| Animal Diseases | 2 | 1986 | 4 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 279 | 0.010 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 1995 | 9 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 52 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1196 | 0.010 |
Why?
|
| Cerebellum | 1 | 1997 | 247 | 0.010 |
Why?
|
| Trigeminal Nerve | 1 | 1995 | 18 | 0.010 |
Why?
|
| Dystonia | 1 | 1995 | 29 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1995 | 62 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1995 | 67 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1995 | 71 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 1996 | 485 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1995 | 79 | 0.010 |
Why?
|
| Tongue | 1 | 1995 | 57 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1981 | 2379 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1996 | 1195 | 0.010 |
Why?
|
| Hormones | 1 | 1995 | 141 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 1995 | 77 | 0.010 |
Why?
|
| Epithelium | 1 | 1995 | 319 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1995 | 193 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1994 | 273 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1973 | 112 | 0.010 |
Why?
|
| Tritium | 2 | 1973 | 133 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1995 | 468 | 0.010 |
Why?
|
| Uridine | 2 | 1973 | 56 | 0.010 |
Why?
|
| Alleles | 1 | 1996 | 1128 | 0.010 |
Why?
|
| Wound Healing | 1 | 1995 | 344 | 0.010 |
Why?
|
| Sucrose | 2 | 1973 | 64 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 1219 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1993 | 148 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1992 | 30 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1993 | 348 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 8489 | 0.010 |
Why?
|
| Lectins | 1 | 1992 | 84 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1992 | 165 | 0.010 |
Why?
|
| Hospitalization | 1 | 1997 | 849 | 0.010 |
Why?
|
| Cell Movement | 1 | 1995 | 758 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 1686 | 0.010 |
Why?
|
| Survival Rate | 1 | 1995 | 1863 | 0.010 |
Why?
|
| Chromium Isotopes | 1 | 1970 | 1 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1994 | 683 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1970 | 23 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1970 | 27 | 0.010 |
Why?
|
| Hematocrit | 1 | 1970 | 68 | 0.010 |
Why?
|
| Splenectomy | 1 | 1970 | 82 | 0.010 |
Why?
|
| Mesentery | 1 | 1970 | 45 | 0.010 |
Why?
|
| Bilirubin | 1 | 1970 | 125 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1970 | 85 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1970 | 149 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1970 | 255 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1970 | 183 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1988 | 47 | 0.000 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1988 | 76 | 0.000 |
Why?
|
| Pregnancy | 2 | 1988 | 2894 | 0.000 |
Why?
|
| Hybridization, Genetic | 1 | 1968 | 104 | 0.000 |
Why?
|
| Paralysis | 1 | 1987 | 23 | 0.000 |
Why?
|
| Denervation | 1 | 1987 | 34 | 0.000 |
Why?
|
| Fatigue | 1 | 1987 | 174 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1970 | 533 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1995 | 4213 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1986 | 148 | 0.000 |
Why?
|
| Arteriosclerosis | 1 | 1986 | 113 | 0.000 |
Why?
|
| Pain | 1 | 1987 | 391 | 0.000 |
Why?
|
| Ovary | 1 | 1986 | 258 | 0.000 |
Why?
|
| Aorta | 1 | 1986 | 280 | 0.000 |
Why?
|
| Medulloblastoma | 1 | 1984 | 36 | 0.000 |
Why?
|
| AKR murine leukemia virus | 2 | 1973 | 2 | 0.000 |
Why?
|
| Sural Nerve | 1 | 1983 | 19 | 0.000 |
Why?
|
| DNA | 1 | 1968 | 1294 | 0.000 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1983 | 86 | 0.000 |
Why?
|
| Pepstatins | 1 | 1982 | 3 | 0.000 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1983 | 131 | 0.000 |
Why?
|
| Calcinosis | 1 | 1984 | 224 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1982 | 71 | 0.000 |
Why?
|
| Ganglia, Autonomic | 1 | 1982 | 5 | 0.000 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 1982 | 66 | 0.000 |
Why?
|
| Shoulder | 1 | 1982 | 42 | 0.000 |
Why?
|
| Neuroma, Acoustic | 1 | 1982 | 20 | 0.000 |
Why?
|
| Nevus | 1 | 1982 | 15 | 0.000 |
Why?
|
| SSPE Virus | 1 | 1981 | 2 | 0.000 |
Why?
|
| Rhabdomyosarcoma | 1 | 1982 | 40 | 0.000 |
Why?
|
| Measles virus | 1 | 1981 | 14 | 0.000 |
Why?
|
| Neurilemmoma | 1 | 1982 | 34 | 0.000 |
Why?
|
| Leg | 1 | 1982 | 137 | 0.000 |
Why?
|
| Adrenal Medulla | 1 | 1982 | 46 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1982 | 299 | 0.000 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1980 | 10 | 0.000 |
Why?
|
| Carbohydrates | 1 | 1980 | 47 | 0.000 |
Why?
|
| Poliovirus | 1 | 1980 | 23 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1980 | 232 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1982 | 532 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1978 | 32 | 0.000 |
Why?
|
| Biotransformation | 1 | 1978 | 50 | 0.000 |
Why?
|
| Methods | 1 | 1978 | 152 | 0.000 |
Why?
|
| Melanoma | 1 | 1982 | 459 | 0.000 |
Why?
|
| Skin Neoplasms | 1 | 1982 | 546 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1980 | 2818 | 0.000 |
Why?
|
| United States | 1 | 1986 | 6672 | 0.000 |
Why?
|
| Leukemia Virus, Feline | 1 | 1973 | 1 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1973 | 28 | 0.000 |
Why?
|
| Goats | 1 | 1973 | 18 | 0.000 |
Why?
|
| Rauscher Virus | 1 | 1973 | 8 | 0.000 |
Why?
|
| Haplorhini | 1 | 1973 | 81 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1973 | 268 | 0.000 |
Why?
|
| Cats | 1 | 1973 | 303 | 0.000 |
Why?
|
| Retroviridae | 1 | 1973 | 79 | 0.000 |
Why?
|
| Swine | 1 | 1973 | 555 | 0.000 |
Why?
|